PROSTATEgen
The ProstatoGen test is a genetic analysis that allows for the assessment of the relative risk of prostate cancer by analyzing the presence of genes associated with this type of cancer.
ABOUT PROSTATOGEN
Prostate cancer tends to occur in men over the age of 50 and develops slowly and without symptoms. Early detection of predisposition to prostate cancer allows for the reduction of the disease risk by following specific recommendations.
WHO AND WHEN SHOULD BE TESTED?
ProstatoGen is primarily intended for individuals with a family history of prostate cancer, as well as all men approaching the age of 50 who wish to understand their risk of having this condition.
RESULTS AND INTERPRETATION
ProstatoGen is based exclusively on genetic analysis conducted using a blood or saliva sample.
– Detailed individual results that are valid for a lifetime
– Identification of risk factors
– The main methods for effectively addressing them
– Personalized recommendations for nutrition and lifestyle.